Measuring patient safety: the need for prospective detection of adverse events
Bates, D.W.
Studies in Health Technology and Informatics 148: 3
2009
ISSN/ISBN: 0926-9630 PMID: 19957414 Document Number: 630635
Document emailed within 1 workday
Related Documents
Bezruchka, S. 2001: Adverse events in British hospitals. Expanded definition of adverse events is needed Bmj 322(7299): 1427Sánchez Muñoz, L.A.; Castiella Herrero, J.; Sanjuán Portugal, F.J.; Naya Manchado, J.; Alfaro Alfaro, M.J. 2007: Usefulness of MBDS in detection of adverse drug events Anales de Medicina Interna 24(3): 113-119
Popoola, T.D.; Awodele, O.; Oshikoya, K.A. 2016: A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria African Journal of Medicine and Medical Sciences 45(2): 179-187
Albayrak, S.; Ozhan, H.; Aslantas, Y.; Ekinozu, I.; Tibilli, H.; Kayapinar, O. 2015: Predictors of major adverse cardiovascular events; results of population based MELEN study with prospective follow-up European Review for Medical and Pharmacological Sciences 19(8): 1446-1451
Tienboon, P.; Jaruwangsanti, N. 2014: A prospective analytical study of the effects and adverse events of alendronate (Aldren70) treatment in Thai postmenopausal women Journal of the Medical Association of Thailand 97(6): 621-628
Debois, H.; Loupi, E.; Saliou, P. 2002: Surveillance of the safety of intravesical BCG therapy in France: quantitative analysis of serious adverse events notified over a period of five years Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 12(4): 604-608
Lassere, M.N.D.; Johnson, K.R.; Boers, M.; Carlton, K.; Day, R.O.; de Wit, M.; Edwards, I.Ralph.; Fries, J.F.; Furst, D.E.; Kirwan, J.R.; Tugwell, P.S.; Woodworth, T.G.; Brooks, P.M. 2005: Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update Journal of Rheumatology 32(10): 2037-2041
Soejima, M.; Kawaguchi, Y.; Hara, M.; Kamatani, N. 2008: Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis Journal of Rheumatology 35(4): 724
Merlin, Béatrice.; Chazard, E.; Pereira, S.; Serrot, E.; Sakji, S.; Beuscart, Régis.; Darmoni, S. 2010: Can F-MTI semantic-mined drug codes be used for adverse drug events detection when no CPOE is available? Studies in Health Technology and Informatics 160(Pt 2): 1025-1029
Welch, V.; Singh, G.; Strand, V.; Fries, J.; Boers, M.; Ramey, D.; Day, R.O.; Brooks, P.; Tugwell, P.; Clinch, J.; Kristjansson, B. 2001: Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index Journal of Rheumatology 28(5): 1188-1191
Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431
Hazir, T.; Begum, K.; El Arifeen, S.; Khan, A.M.; Huque, M.Hamidul.; Kazmi, N.; Roy, S.; Abbasi, S.; Rahman, Q.Sadeq-Ur.; Theodoratou, E.; Khorshed, M.Shayema.; Rahman, K.Mizanur.; Bari, S.; Kaiser, M.Mahfuzul.Islam.; Saha, S.K.; Ahmed, A.S.M.Nawshad.Uddin.; Rudan, I.; Bryce, J.; Qazi, S.Ahmad.; Campbell, H. 2013: Measuring coverage in MNCH: a prospective validation study in Pakistan and Bangladesh on measuring correct treatment of childhood pneumonia Plos Medicine 10(5): E1001422
Al-Ahmadi, T.A. 2009: Measuring Patient Safety Culture in Riyadh's Hospitals: a Comparison between Public and Private Hospitals Journal of the Egyptian Public Health Association 84(5-6): 479-500
Kodama, F.; Mohri, H.; Motomura, S.; Fukawa, H.; Tanabe, J.; Koharasawa, H.; Kanamori, H.; Hashimoto, Y.; Harano, H.; Sakai, R.; Tomita, N.; Fujimaki, K.; Takemura, S.; Hattori, M. 2002: Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 273-279
Offenbartl, K. 2008: "From blame and shame to patient safety work in an educational and nourishing environment". Patient safety issues belong on the "workshop floor" Lakartidningen 105(15): 1112
Schaller, M.; Hackl, W.O.; Ammenwerth, E. 2018: Improving Patient Safety by Reusing Clinical Routine Data - An Expert Survey on Patient Safety Indicators Studies in Health Technology and Informatics 248: 300-306
Okada, K. 2011: Adverse events following vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1639-1643
Cooper, J.B.; Gaba, D.M.; Liang, B.; Woods, D.; Blum, L.N. 2000: The National Patient Safety Foundation agenda for research and development in patient safety Medgenmed: Medscape General Medicine 2(3): E38
Yamashita, H.; Tsukayama, H.; Tanno, Y.; Nishijo, K. 1998: Adverse events related to acupuncture JAMA 280(18): 1563-1564
Kapellen, T.M.; Gebauer, C.M.; Brosteanu, O.; Labitzke, B.; Vogtmann, C.; Kiess, W. 2009: Higher rate of cord-related adverse events in neonates with dry umbilical cord care compared to chlorhexidine powder. Results of a randomized controlled study to compare efficacy and safety of chlorhexidine powder versus dry care in umbilical cord care of the newborn Neonatology 96(1): 13-18